Related Experiment Video
Updated: Sep 23, 2026

Simple and Fast Rolling Circle Amplification-Based Detection of Topoisomerase 1 Activity in Crude Biological Samples
Published on: December 2, 2022
Spatial organization of topoisomerase I-mediated DNA cleavage induced by camptothecin-oligonucleotide conjugates
Paola B Arimondo1, Stéphane Angenault, Ludovic Halby
1Laboratoire de Biophysique, USM0503 Muséum National d'Histoire Naturelle, UMR8646 CNRS, UR565 INSERM, 43 Rue Cuvier, 75231 Paris Cedex 05, France. arimondo@mnhn.fr
Abstract:
Triple helix-forming oligonucleotides covalently linked to topoisomerase I inhibitors, in particular the antitumor agent camptothecin, trigger topoisomerase I-mediated DNA cleavage selectively in the proximity of the binding site of the oligonucleotide vector. In the present study, we have performed a systematic analysis of the DNA cleavage efficiency as a function of the positioning of the camptothecin derivative, either on the 3' or the 5' side of the triplex, and the location of the cleavage site. A previously identified cleavage site was inserted at different positions within two triplex site-containing 59 bp duplexes. Sequence-specific DNA cleavage by topoisomerase I occurs only with triplex conjugates bearing the inhibitor at the 3'-end of the oligonucleotide and on the oligopyrimidine strand of the duplex. The lack of targeted cleavage on the 5' side is attributed to the structural differences of the 3' and 5' duplex-triplex DNA junctions. The changes induced in the double helix by the triple-helical structure interfere with the action of the enzyme according to a preferred spatial organization. Camptothecin conjugates of oligonucleotides provide efficient tools to probe the organization of the topoisomerase I-DNA complex and will be useful to understand the functioning of topoisomerase I in living cells.
Insights
Triple helix-forming oligonucleotides conjugated with camptothecin selectively induce DNA cleavage via topoisomerase I. This targeted DNA damage is sequence-specific and depends on inhibitor positioning, offering insights into enzyme function.
Area of Science:
- Molecular Biology
- Biochemistry
- Genetics
Background:
- Triple helix-forming oligonucleotides (TFOs) can bind specific DNA sequences.
- Topoisomerase I (Top1) is crucial for managing DNA topology during replication and transcription.
- Camptothecin is a potent Top1 inhibitor used in cancer therapy.
Purpose of the Study:
- To investigate the DNA cleavage efficiency of TFOs linked to camptothecin derivatives.
- To determine the influence of camptothecin positioning (3' vs. 5') on Top1-mediated DNA cleavage.
- To analyze the impact of cleavage site location within duplex DNA on TFO-conjugate activity.
Main Methods:
- Synthesis of TFO-camptothecin conjugates with varying inhibitor positions.
- Construction of 59 bp duplex DNA containing triplex binding sites.
- Assays to measure Top1-mediated DNA cleavage at specific sites.
Main Results:
- Sequence-specific DNA cleavage occurred only when camptothecin was attached to the 3'-end of the oligonucleotide and on the oligopyrimidine strand.
- Cleavage was dependent on the inhibitor's position relative to the triplex binding site.
- No targeted cleavage was observed with 5'-end conjugates, attributed to structural differences at the DNA junction.
Conclusions:
- Camptothecin-TFO conjugates enable targeted Top1-mediated DNA cleavage.
- The spatial organization of the Top1-DNA complex influences cleavage efficiency.
- These conjugates are valuable tools for studying Top1 activity and DNA organization in cellular contexts.
More Related Videos
Related Concept Videos
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. Type I...
Inhibitors of Bacterial DNA Synthesis
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
DNA Helicases
Drugs that Destabilize Microtubules

